You are here

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Biomarkers, immune monitoring, and novel technologies
79 Tumor-immune signatures associated with response or resistance to tislelizumab (Anti-PD-1) in esophageal squamous cell carcinoma (ESCC)

 

Online download statistics by month:

Online download statistics by month: November 2020 to November 2024

AbstractFullPdf
Nov 2020161041
Dec 202054012
Jan 20211102
Feb 20211403
Mar 20213807
Apr 20212203
May 2021709
Jun 2021003
Jul 20210011
Aug 2021004
Sep 2021009
Oct 202118018
Nov 202134013
Dec 20211206
Jan 20222603
Feb 20221604
Mar 20225801
Apr 202214204
May 20223602
Jun 20223404
Jul 20222604
Aug 20221807
Sep 20224004
Oct 20224002
Nov 20223506
Dec 20223600
Jan 20232003
Feb 20232004
Mar 20231802
Apr 20231001
May 20231801
Jun 2023400
Jul 20231402
Aug 2023800
Sep 2023800
Oct 20231202
Nov 20231401
Dec 20233601
Jan 20242000
Feb 20241801
Mar 20242604
Apr 20241401
May 20241601
Jun 20242204
Jul 20241600
Aug 2024602
Sep 20241401
Oct 20241004
Nov 20242209
Total12440226